
Large-scale human trials validates the use of genomic-based test for lung cancer detection.
A new test co-developed by a Boston University School of Medicine (BUSM) researcher will allow patients suspected of having lung cancer to be subjected to fewer and less-invasive tests to … Continue Reading Large-scale human trials validates the use of genomic-based test for lung cancer detection.